GINS, a heterotetramer of SLD5, PSF1, PSF2, and PSFS proteins, is an emerging chromatin factor recognized to be involved in the initiation and elongation step of DNA replication. Although the yeast and Xenopus GINS genes are well documented, their orthologous genes in higher eukaryotes are not fully characterized. In this study, we report the genomic structure and transcriptional regulation of mammalian GINS genes. Serum stimulation increased the GINS mRNA levels in human cells. Reporter gene assay using putative GINS promoter sequences revealed that the expression of mammalian GINS is regulated by 17P-Estradiolstimulated estrogen receptor a, and human PSFS acts as a gene responsive to transcription factor E2F1. The goal of this study is to present the current data so as to encourage further work in the field of GINS gene regulation and functions in mammalian cells.
Introduction
In eukaryotic cells, chromosomal DNA replication requires the formation of a prereplicative complex (pre-RC) on origins, and assembly of other replication proteins in the S phase of the cell cycle to load the DNA polymerases to initiate DNA synthesis (1 ). The Cdc45 protein is crucial for the latter step of DNA replication initiation, as it activates the pre-RC that contains the MCM helicase. In addition to these proteins, GINS, a heterotetramer consisting of SLD5, PSFl (partner of Sld five l), PSF2, and PSF3 proteins, was recently identified as a loading factor for DNA polymerases, and as being required to separate the DNA strands at the replication fork in yeast and Xenopus egg extracts (2-6). Although GINS is supposed to play a significant role in eukaryotic cells, the biological functions of its orthologous genes in higher eukaryotes are not fully characterized. A comparative genomic approach for the study of the GINS orthologous genes in higher eukaryotes could help in the understanding of a common regulatory mechanism for mammalian GINS genes.
*Corresponding author .
E-mail: yoshidaQisc.meiji.ac.jp Geno. Prot. Bioinfo.
In this study, we characterized the human and mouse GINS orthologous genes by using bioinformatics techniques. The gene structures, chromosomal 1o-calization, protein homology, and expression profiles are discussed. In addition, transcriptional regulations of human and mouse GINS genes are characterized. This is the first report of the identification of GINS up-regulation by serum stimulation and 17P-Estradiol (E2)-stimulated estrogen receptor a (ERa), and also is the first report that the putative promoter region of human PSF3 is responsive to transcription factor E2F1.
Results
Characterization of the GINS orthologous genes in higher eukaryotes
To investigate the functional importance of the GINS proteins in higher eukaryotes, we initially compared the amino acid sequences among human, chimpanzee, orangutan, dog, cow, mouse, and rat GINS proteins. As summarized in Table 1, human PSF1, PSF2,  PSF3, and SLD5 proteins showed 92%-94%, 86%-loo%, 89%-99%, and 84%-88% total amino acid tity, respectively, with the mammalian orthologous were well conserved. Human (mouse) PSF1, PSF.2, genes. Next, we sought to determine the gene struc-PSF3, and SLDS genes had 7 (7), 5 (5), 3 (3), and tures of the human and mouse GINS genes. For this 8 (8) exons, respectively (Tables 2-5 ). The prepurpose, we searched for a genome database using hu-cise exon-intron boundaries of the human and mouse man and mouse GINS cDNAs as query sequences in GINS genes were determined based on the consenthe BLAST program. Consequently, human (mouse) sus sequence ("gt. . . ag" rule of intronic sequence) PSFl, PSF2, PSF3, and SLDS gene fragments were of exon-intron junctions and the codon usage. One identified within the genome sequences NT-011387 exception was found in intron2 ("gg. . . ag") of the (AL808125), NT-010498 (AC103360), NT-086851 human PSF3 gene (Table 4) . The human (mouse) (AC113951), and NT-086740 (AC126038), respec-PSFl, PSFZ, PSF3, and SLDS genes were mapped tively. The gene structures, especially the exon length to 20~11.21 (2G3), 16q24.1 (8E1), 16q21 (8C5), and and location of the human and mouse GINS genes 8~11.21 (8A3), respectively (Table 6 ). Dog  94  196  94  185  94  216   88   292  c o w  92  196  86  340  93  216  84  489  Mouse  92  196  92  185  89  216  87  223  Rat  93  196  92  434  90  216  88  223 *The percentage conservation in mammals, including chimpanzee, orangutan, dog, cow, mouse, and rat proteins relative to the sequence of the human protein (taken as 100%) is presented. The lengths of the amino acid (aa) sequences are indicated. "-" indicates that the protein is not deposited in the databases. Havashi et al. 
Expression profiles of human and mouse GINS mRNAs
In silico analysis revealed that the expression patterns of the GINS mRNA in human/mouse tissues and organs were quite different ( Figure 1A ). On the other hand, during the developmental stages, the GINS mRNA expression patterns were quite similar: highest in the embryo and juvenile stages, lower in adults, and no expression in the neonatal stage ( Figure 1B ). Next, we attempted a search for GINS mRNA in public databases. The Gene Expression Omnibus (GEO) database search revealed that the SLD5 gene is downregulated under two growth arrest conditions, namely, serum deprivation and contact inhibition, in T98G cancer cells (Accession No. GDSSll), and PSFl is an estrogen target in human breast carcinoma MCF7 cells (Accession No. GDSll8). It is of interest that GINS is regulated by serum stimulation, because the mRNA level of a known DNA replication initiator is reported to be induced when cells enter the G1/S phase of the cell cycle (7,B) . To substantiate this evidence, growth arrest of Sms-2 cells was induced by incubation in serum-free medium for three days, then the cells were re-entered into the cell cycle with the readdition of 20% fetal bovine serum (FBS). Twentyfour hours after the serum re-addition, the GINS mRNA level was found to be up-regulated, while the GAPDH mRNA level remained unchanged ( Figure  1C ). At this time point, cyclin A protein accumulation was clearly observed as the cells re-entered the cell cycle (data not shown).
Transcriptional regulation of the human and mouse GINS genes
To gain more insights into the functions of the human and mouse GINS genes, we searched the proximal region of the transcription start site for potential ciselements using the Transfac software (ver. 4.0, cut-off 85). The E2F-and/or NF-Y-binding consensus sequences were identified to be surrounded by GC-rich sequences in the putative promoter region of the human and mouse GINS genes (Figure 2A ). In addition to that by serum stimulation, many genes involved Geno. Prot. Bioinfo.
in DNA replication initiation were found to be regulated by transcription factor E2F1 ( 7 , B ) . To demonstrate the importance of the putative E2F-binding element in the basal promoter activity, we generated human PSFl, mouse Psf., human PSF3, and mouse Sld5 promoter-luciferase constructs. As shown in Figure 2B , human PSFl, mouse P s f . , human PSF3, and mouse Sld5 promoter constructs showed approximately 265-, 37-, 0.6-, and 82-fold increases in activity, respectively, as determined by measuring the relative luciferase activities, taking the activity in the control luciferase vector pGL3-Basic as 1. Exogenous coexpression of E2F1 caused up to approximately 1-, 0.2-, 8.3-, and 0.9-fold increases in the human PSFI, mouse Psf2, human PSF3, and mouse Sld5 promoter activities, respectively, as compared to that of the pcDNA3 control vector ( Figure 2C ). These results suggest that the E2F-binding motif plays critical roles in the E2F1-mediated human PSF3 promoter activity. This is the first report of the E2F1-dependent regulation of the PSF3 gene.
To determine whether E2 also regulates GINS promoter activity, HeLa cells were cultured with E2, and the effect of cotransfection with ERa was measured. Interestingly, the initial transient transfection studies with pGL3-hPSF1, -mPsf2, -hPSF3, and -mSld5 reporter vector constructs showed that treatment with 100 nM of E2 resulted in 1.2-, 0.8-, 1.3-, and 0.9-fold increases in the reporter gene activities, respectively, as compared to that after DMSO treatment ( Figure 2D ). However, following cotransfection with ERa, there was an enhanced (ll-24-fold) induction of reporter gene activity after treatment with 100 nM of E2 as compared to that in the pcDNA3 control vector ( Figure 2D ). These results suggest that the GINS genes are regulated by E2 via ERa in cultured cells.
Discussion
In the present study, we attempted to characterize the gene structure and transcriptional regulation of the human and mouse GINS genes. Studies using bioinformatics techniques revealed that the GINS proteins are well conserved among several mammals. In addi- tion, conservation of the gene structure, including the putative promoter region between human and mouse GINS genes, suggests that their transcriptional regulation might also be similar. We succeeded in identifying PSF3 as an E2F1-regulated gene, and that the human and mouse GINS genes are regulated by growth stimuli, including serum addition and E2 treatment. In contrast to the rapid progress of research on the yeast and Xenopus GINS, only a few reports have been published regarding mammalian GINS. For example, mice homozygous for the PSFl gene died in utero around the time of implantation, indicating that PSFl protein may be required during early embryogenesis ( 9 ) . cDNA microarray analyses revealed that the PSF2 gene is frequently up-regulated in cholangiocarcinoma, suggesting that PSF2 protein may play an important role in the development of this type of liver cancer ( 1 0).
The action of E2 on its target cells is mediated via ERa or ERP, which function as ligand-activated transcription factors regulating gene expression. E2 has been shown to play a central role in breast cancer development; therefore it is important to find out the critical downstream targets of E2/ERol action. The majority of E2 target genes are characterized by imperfect estrogen-responsive element (ERE: AGGT-CANNNTGACCT) sequences or complex organiaation with the presence of half an ERE site. Interestingly, many E2-responsive genes, which do not contain ERE but do contain other &-elements, such as Spl, have also been described. ERs can regulate transcription by direct protein-protein interaction with Spl (11) . Indeed, the GINS promoter constructs used in this study contained GC-rich sequences, but no ERElike sequences. The mitogenic effect of ERa is me-162
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diated at the regulation level of kinases that govern the transition from the GO/G1 to S phase of the cell cycle, such as under the influence of cyclin D-Cdk4/6 and cyclin E-Cdk2, to increase phosphorylation of the retinoblastoma protein (pRb) (12) . pRb physically interacts with E2F1 to yield a transcriptionally repressed complex. Phosphorylated pRb results in dissociation of the pRbE2F1 complex and subsequent up-regulation of E2F1-dependent genes (13-1 5) . Although the regulation of E2F1-dependent transactivai tion is closely linked to pRb, E2 is also known to induce E2F1 mRNA and protein in human cultured cells (16) . This could mean that the E2F1-dependent regulation of PSF3 expression may be partially mediated by E2. More detailed studies are needed to clearly elucidate the mechanism by which GINS affects the development of breast cancer.
In conclusion, our study clearly demonstrated that a comparative genomic approach for the GINS orthologous genes in higher eukaryotes could help in the understanding of common or unique regulatory mechanisms for important genes. We identified the conserved gene structure and for the first time characterized the promoter region of the human and mouse GINS genes. This is the first report of the identification of the induction of GINS by serum stimulation and E2/ERol-induced genes, and is also the first report that human PSF3 gene is regulated by transcription factor E2F1.
Materials and Methods

Bioinformatics
Bioinformatics techniques were employed as previously described (17, 18) 
Plasmids
The human and mouse GINS promoter fragments were generated by polymerase chain reaction (PCR) from genomic DNA and ligated into the pGL3-Basic vector (Promega, Madison, USA). 
RT-PCR
Total cellular RNA was extracted from Saos-2 cells using Trizol reagent (Invitrogen, Carlsbad, USA) according to the manufacturer's instruction. RT-PCR was performed with the Superscript RT-PCR system according to the manufacturer's instruction (Invitrogen). PCR was performed as follows: denaturation at 94°C for 2 min, followed by multiple cycles at 94°C for 15 s, 55°C for 30 s, and 68°C for 30 s. As a control, a GAPDH (glyceraldehyde-3-phosphate dehydrogenase) primer set was used (R&D Systems, Minneapolis, USA). The amplified products were separated on 1% agarose gels and visualized under ultraviolet transillumination.
